Meet our partners
Americas Partner
Sanofi
Sanofi is a global healthcare leader focused on patients’ needs, engaged in the research, development, manufacturing and marketing of therapeutic solutions focused on patients’ needs. Sanofi has core strengths in diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and Sanofi Genzyme. Read more at en.sanofi.com
News

Mar 2016 Sanofi and Regeneron announce topline results of phase 3 monotherapy study demonstrating superiority of SARILUMAB vs. ADALIMUMAB in patients with active rheumatoid arthritis

Feb 2016 FDA accepts Sanofi new drug application for once-daily fixed-ratio combination of insulin GLARGINE A LIXISENATIDE

Dec 2015 Sanofi: DENGVAXIA®, world's first dengue vaccine, approved in Mexico


From the OneStart London Bootcamp 2016

Panel Discussion

Panel Discussion: Navigating Critical Decision Points

  • Lynne Murray, PhD, MBA, Partnering & Strategy, MedImmune (Chair)
  • Sarah Holland, DPhil (Oxon), MBA, External Science and Partnering, Sanofi
  • Matthias Essenpreis, PhD, Chief Technology Officer (Diagnostics), F.Hoffmann-La Roche Ltd.
  • Georg Buchner, PhD MBA, Licensing Director, Amgen 
  • Jonathan Tobin, PhD, MBA, Principal, Healthcare Venture, Imperial Innovations

Mentors
Paul Jansen
Global Head Medical Devices at Sanofi-Aventis + more
Strong drug/ biologics device development experience (registration, CMC, manufacturing, quality, business development). Demonstrated success in cross cultural work environments (Japan and EU) and excellent project management skills. Demonstrated ability to think strategically, creatively and tactically ensuring that thoughtful plans translate into coordinated action. Strong leader, having developed and led through many difficult situations. Excellent relationship skills. Highly respected by peers. Gets results through people (internally and from alliances).
Sarah Holland
Head of Europe, External Science & Partnering at Sanofi + more
Responsible for cultivating relationships and bringing forward innovative external opportunities from key stakeholders located across Europe. Groups based in France, Germany, the UK, Israel and Russia form the European External Science and Partnering team, charged with building a deep network of external collaborators and working to become the partner of choice for all external innovation sourced across Europe. Specialties: Cross-functional team leadership, pharmaceutical M&A, business development, strategic planning and global marketing.
Vijayalakshmi Agnani
Head of Office, External Innovation Operations | Strategy, Science Policy and External Innovation at Sanofi + more
Vijayalaksmi (Viju) Agnani joined Sanofi as Head of Office, External Operations in Feb 2015.She joined Sanofi after an 8 year career in the research division at Merck and Co. Most recently, Viju was Manager, Strategic Operations where she managed a number of external research alliances at Merck Research Labs, which included working with biotechnology companies, CROs and premier academic institutions around the world. As Partner Relationship Manager she led all day-to-day operational and tactical aspects of the partnerships. While in this role, she spearheaded the launch of the Merck Innovation Network initiative, a first of its kind Open Innovation effort at Merck. Prior to that, she was a biologist at the Cardiovascular Diseases and In Vitro Pharmacology groups at Merck where she led biochemistry and biophysics research supporting Merck’s Cardiovascular portfolio.
Teams Mentored